IMI (International Medical Industries, Inc.) Releases Tamper Evident Caps With Incorporated RFID

IMI (International Medical Industries) bolsters expertise in secure drug delivery products with the release of their Prep-Lock Tamper Evident Cap for IV Syringes with incorporated Radio Frequency Identification (RFID) technology.

IMI's Prep-Lock line of Tamper Evident Products helps ensure medication safety from pharmacy to patient.

Prep-Lock Tamper Evident Caps are an established method for providing safeguards to ensure medication safety and are utilized by 84% of the top outsource compounders in the US. RFID technology enables real-time scanning that optimizes inventory management, efficiency, and medication safety while creating quantifiable pharmaceutical supply chain benefits by providing item-level inventory visibility.

Every drug secured with a Tamper Evident Cap featuring RFID is trackable throughout its entire lifecycle. These two powerful technologies in combination enhance workflow efficiencies, eliminate time-consuming manual inventory control processes, provide assistance with growing regulatory demand, and supply a comprehensive strategy to prevent, detect, and resolve drug diversion events. In addition, Tamper Evident Caps with incorporated RFID technology offer a significant reduction in RFID implementation costs. IMI joined DoseID, a consortium of RFID proponents in 2020 with the goal of supporting the interoperability, quality, and performance of RFID tagged products. The DoseID RFID tag now incorporated in the Prep-Lock Tamper Evident Cap is certified by Auburn University RFID Lab's ARC Program to ensure the high standards set by the DoseID consortium are met and that those standards meet the needs of the healthcare industry.